FONAR Corporation

NasdaqCM FONR

FONAR Corporation Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 42.43%

FONAR Corporation Gross Profit Margin is 42.43% for the Trailing 12 Months (TTM) ending September 30, 2024, a 0.37% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • FONAR Corporation Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 42.27%, a -11.56% change year over year.
  • FONAR Corporation Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 47.80%, a 0.73% change year over year.
  • FONAR Corporation Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 47.45%, a -5.95% change year over year.
  • FONAR Corporation Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 50.45%, a 2.99% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
NasdaqCM: FONR

FONAR Corporation

CEO Mr. Timothy R. Damadian M.D.
IPO Date Oct. 29, 1981
Location United States
Headquarters 110 Marcus Drive
Employees 520
Sector Industrials
Industries
Description

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.

Similar companies

BDSX

Biodesix, Inc.

USD 1.15

-7.26%

XGN

Exagen Inc.

USD 3.00

-3.85%

SERA

Sera Prognostics, Inc.

USD 6.37

0.63%

BNR

Burning Rock Biotech Limited

USD 6.55

-6.69%

SHC

Sotera Health Company

USD 12.76

-2.52%

CSTL

Castle Biosciences, Inc.

USD 25.46

-2.64%

STIM

Neuronetics, Inc.

USD 2.16

-7.69%

StockViz Staff

January 15, 2025

Any question? Send us an email